Figure 1
From: TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
TMED3 expression is up-regulated in HCC and in cases of PVTT.
(A) Relative TMED3 mRNA expression levels in 60 cases of HCC, including 25 MI and 35 NMI, were analyzed by RT-PCR and normalized to β-actin. (B) Relative TMED3 mRNA expression levels in 30 cases of HCC with PVTT were analyzed by RT-PCR and normalized to β-actin. (C) The high TMED3 expression group had a shorter RFS than the low TMED3 expression group. (D) The high TMED3 expression group had a shorter OS than the low TMED3 expression group. *p < 0.05, **p < 0.01, ***p < 0.001.
